Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Shenzhen Bioeasy Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥8.6

2024-10-29

Market Capitalization

¥3.4 B

2024-10-29

Revenue

¥220.9 M

FY, 2024

CreditSafe Score

?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024
Revenue193.4M218.0M234.4M594.1M673.7M239.9M220.9M
Cost of goods sold64.8M65.9M63.7M169.5M298.8M127.2M65.9M
Gross profit138.4M171.1M193.1M424.9M385.5M123.2M157.5M
Gross profit margin, %71.6%78.5%82.4%71.5%57.2%51.4%71.3%
Operating expense total68.4M92.9M106.4M160.4M247.7M136.1M111.6M
Depreciation and amortization5.4M9.7M13.2M39.1M13.6M
EBITDA70.1M78.2M86.6M262.6M134.0M(67.8M)35.6M
EBITDA margin, %36.2%35.9%36.9%44.2%19.9%-28.3%16.1%
EBIT82.4M94.7M76.0M268.6M83.7M(126.5M)33.4M
EBIT margin, %42.6%43.4%32.4%45.2%12.4%-52.7%15.1%
Interest income211.0K631.0K385.0K2.1M3.6M7.6M8.3M
Interest expense370.0K2.4M4.1M10.6M18.7M
Pre tax profit84.7M106.0M73.9M268.0M94.9M(177.8M)19.7M
Income tax expense10.8M13.7M8.5M31.6M12.2M7.2M3.1M
Net Income73.9M92.3M65.4M236.5M82.7M(185.0M)16.6M

Footer menu